Adult stem cells have the ability repair a variety of tissues. Mesenchymal stem cells (MSCs) can differentiate into osteoblasts, chondrocytes, adipocytes, neurocytes and hepatocytes to repair bone, cartilage, connective tissue, nerves and liver tissue. This article discusses clinical applications of bone marrow aspirate concentrate (BMAC), the basic science of MSCs from BMAC and the differences between “amniotic stem cells” and BMAC.¹
Researchers have experimented with various types of stem cell therapy, including stem cells derived from adipose tissue, allogeneic stem cells or “amniotic stem cells” and autologous MSCs harvested from bone marrow. Researchers have examined the therapeutic effects of MSCs from bone marrow for orthopedic conditions like knee and hip osteoarthritis, neurological conditions like multiple sclerosis, and cardiovascular conditions like critical limb ischemia. Researchers have found BMAC procedures to be safe and improve patient outcomes without adverse effects.